These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2906888)

  • 21. Controlled trial comparing olsalazine and sulphasalazine for maintenance treatment of ulcerative colitis.
    Jewell DP; Ireland A
    Scand J Gastroenterol Suppl; 1988; 148():45-7. PubMed ID: 2906477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intermittent therapy with high-dose 5-aminosalicylic acid enemas for maintaining remission in ulcerative proctosigmoiditis.
    d'Albasio G; Trallori G; Ghetti A; Milla M; Nucci A; Pacini F; Morettini A
    Dis Colon Rectum; 1990 May; 33(5):394-7. PubMed ID: 1970284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Steady-state kinetics of 5-aminosalicylic acid and sulfapyridine during sulfasalazine prophylaxis in ulcerative colitis.
    Bondesen S; Nielsen OH; Schou JB; Jensen PH; Lassen LB; Binder V; Krasilnikoff PA; Danø P; Hansen SH; Rasmussen SN
    Scand J Gastroenterol; 1986 Aug; 21(6):693-700. PubMed ID: 2875518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine.
    Nakajima H; Munakata A; Yoshida Y
    J Gastroenterol; 1995 Nov; 30 Suppl 8():115-7. PubMed ID: 8563870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral 5-aminosalicylic acid for inducing remission in ulcerative colitis.
    Sutherland L; Roth D; Beck P; May G; Makiyama K
    Cochrane Database Syst Rev; 2000; (2):CD000543. PubMed ID: 10796555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind comparison of slow-release 5-aminosalicylate and sulfasalazine in remission maintenance in ulcerative colitis.
    Mulder CJ; Tytgat GN; Weterman IT; Dekker W; Blok P; Schrijver M; van der Heide H
    Gastroenterology; 1988 Dec; 95(6):1449-53. PubMed ID: 2903110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind comparison of balsalazide, 6.75 g daily, and sulfasalazine, 3 g daily, in patients with newly diagnosed or relapsed active ulcerative colitis.
    Green JR; Mansfield JC; Gibson JA; Kerr GD; Thornton PC
    Aliment Pharmacol Ther; 2002 Jan; 16(1):61-8. PubMed ID: 11856079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of 5-aminosalicylic acid (3 g) and prednisolone phosphate sodium enemas (30 mg) in the treatment of distal ulcerative colitis. A prospective, randomized, double-blind trial.
    Mulder CJ; Tytgat GN; Wiltink EH; Houthoff HJ
    Scand J Gastroenterol; 1988 Oct; 23(8):1005-8. PubMed ID: 3059450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative efficacy of coated, oral 5-aminosalicylic acid (Claversal) and sulphasalazine for maintaining remission of ulcerative colitis. International Study Group.
    Rutgeerts P
    Aliment Pharmacol Ther; 1989 Apr; 3(2):183-91. PubMed ID: 2577483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Sulfasalazine enema in acute left-sided ulcerative colitis (author's transl)].
    Frimberger E; Frühmorgen P; Kühner W; Ottenjann R
    MMW Munch Med Wochenschr; 1980 Sep; 122(36):1233-5. PubMed ID: 6108506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics and therapeutic efficacy of sulfasalazine in patients with mildly and moderately active ulcerative colitis.
    Chen QK; Yuan SZ; Wen ZF; Zhong YQ; Li CJ; Wu HS; Mai CR; Xie PY; Lu YM; Yu ZL
    World J Gastroenterol; 2005 Apr; 11(16):2462-6. PubMed ID: 15832418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of the active moiety of BX661A, a new therapeutic agent for ulcerative colitis, by studying its therapeutic effects on ulcerative colitis induced by dextran sulfate sodium in rats.
    Kimura I; Kawasaki M; Nagahama S; Matsuda A; Kataoka M; Kokuba Y
    Arzneimittelforschung; 1998 Nov; 48(11):1091-6. PubMed ID: 9850431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: a randomized, controlled trial.
    Friedman LS; Richter JM; Kirkham SE; DeMonaco HJ; May RJ
    Am J Gastroenterol; 1986 Jun; 81(6):412-8. PubMed ID: 3518408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of mesalamine suspension enema and oral sulfasalazine for treatment of active distal ulcerative colitis in adults.
    Kam L; Cohen H; Dooley C; Rubin P; Orchard J
    Am J Gastroenterol; 1996 Jul; 91(7):1338-42. PubMed ID: 8677990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of metronidazole and sulfasalazine in the maintenance of remission in patients with ulcerative colitis.
    Gilat T; Leichtman G; Delpre G; Eshchar J; Bar Meir S; Fireman Z
    J Clin Gastroenterol; 1989 Aug; 11(4):392-5. PubMed ID: 2569488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An experiment to determine the active therapeutic moiety of sulphasalazine.
    Azad Khan AK; Piris J; Truelove SC
    Lancet; 1977 Oct; 2(8044):892-5. PubMed ID: 72239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid.
    Dew MJ; Hughes P; Harries AD; Williams G; Evans BK; Rhodes J
    Br Med J (Clin Res Ed); 1982 Oct; 285(6347):1012. PubMed ID: 6127137
    [No Abstract]   [Full Text] [Related]  

  • 38. Olsalazine in the treatment of mild to moderate ulcerative colitis: a randomized, placebo-controlled, double-blind, clinical trial.
    Feurle GE; Theuer D; Velasco S; Barry BA; Wördehoff D; Sommer A; Jantschegk Y; Kruis W
    Scand J Gastroenterol Suppl; 1988; 148():38-9. PubMed ID: 3067338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double-blind comparative study of sulfasalazine and controlled-release mesalazine tablets in the treatment of active ulcerative colitis.
    Munakata A; Yoshida Y; Muto T; Tsuchiya S; Fukushima T; Hiwatashi N; Kobayashi K; Kitano A; Shimoyama T; Inoue M
    J Gastroenterol; 1995 Nov; 30 Suppl 8():108-11. PubMed ID: 8563868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind study.
    Rao SS; Dundas SA; Holdsworth CD; Cann PA; Palmer KR; Corbett CL
    Gut; 1989 May; 30(5):675-9. PubMed ID: 2567266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.